Physician profile
Kenneth F Binmoeller
NPI 1851321715
$507,241.53
in general payments reported to CMS, 2019-2025
12 companies · $42K in 2025
The $42K reported for 2025 was more than what 97% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440K · 2020: $264 · 2021: $3,916 · 2022: $586 · 2023: $3,627 · 2024: $17K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $51K · Travel and Lodging: $4,311 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Food and Beverage: $2,222 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $51,231.15 |
| Travel and Lodging | $4,310.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Food and Beverage | $2,222.19 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $434,826.53 | 2019-2025 | Axios, General - Therapies |
| Micro-Tech Endoscopy USA, INC. | $58,946.38 | 2019-2025 | Goldknife, Dat Device, Eyemax |
| Olympus Corporation | $8,755.00 | 2019 | |
| Cook Medical LLC | $3,562.89 | 2019-2025 | Fusion, Echotip Insight, Hemospray |
| Olympus America INC. | $274.46 | 2019-2024 | Endoclot Phs |
| Medtronic, INC. | $249.63 | 2024 | Endoflip |
| Fujifilm Healthcare Americas Corporation | $235.18 | 2023-2025 | Fujifilm |
| Erbe USA INC | $194.23 | 2024 | |
| Lumendi LLC | $96.44 | 2019 | |
| Braintree Laboratories, INC. | $53.32 | 2019 | |
| Lilly USA, LLC | $29.94 | 2024 | Omvoh |
| Conmed Corporation | $17.53 | 2025 | Conmed Biliary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Binmoeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.